The Angiotensin II Receptor Antagonist Candesartan Is Not Effective in Reducing Portal Hypertension in Patients with Cirrhosis

By  

Digestion, Vol. 75, Iss. 2-3, 2007-06 ,pp. : 122-123

Karger

Access to resources Recommend Favorite

Comparison of the Angiotensin II Receptor Antagonist Irbesartan With Atenolol for Treatment of Hypertension

By STUMPE K. O.   HAWORTH D.   HÖGLUND C.   KERWIN L.   MARTIN A.   SIMON T.   MASSON C.   KASSLER-TAUB K.   OSBAKKEN M.  

Blood Pressure, Vol. 7, Iss. 1, 1998-04 ,pp. : 31-37

Informa Healthcare

Access to resources Recommend Favorite

Combination of Angiotensin II Receptor Antagonist with Calcium Channel Blocker or Diuretic as Antihypertensive Therapy for Patients with Chronic Kidney Disease

By Ishimitsu Toshihiko   Ohno Eri   Nakano Nobuyuki   Furukata Satoshi   Akashiba Akira   Minami Junichi   Numabe Atsushi   Matsuoka Hiroaki  

Clinical and Experimental Hypertension, Vol. 33, Iss. 6, 2011-10 ,pp. : 366-372

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the Effect of Combination Therapy with an Angiotensin II Receptor Blocker and Either a Low-Dose Diuretic or Calcium Channel Blocker on Cardiac Hypertrophy in Patients with Hypertension

By Okura Takafumi   Miyoshi Ken-ichi   Irita Jun   Enomoto Daijiro   Jotoku Masanori   Nagao Tomoaki   Watanabe Kouki   Matsuoka Hiroshi   Ashihara Toshiaki   Higaki Jitsuo  

Clinical and Experimental Hypertension, Vol. 35, Iss. 8, 2013-12 ,pp. : 563-569

Informa Healthcare

Access to resources Recommend Favorite

Treating Hypertension with Angiotensin II Receptor Blockers: A Step Ahead of Blood Pressure Reduction?

By Ruilope Luis M.  

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 1, 2005-01 ,pp. : 9-15

Adis International

Access to resources Recommend Favorite